BBIO - BridgeBio Pharma GAAP EPS of -$0.20 beats by $0.31 revenue of $211.12M beats by $127.34M
2024-05-02 07:55:42 ET
More on BridgeBio Pharma
- BridgeBio Pharma: Assessing Acoramidis' Market Opportunity, Further Upside Potential Evident
- BridgeBio prices $250M stock offering
- BridgeBio Pharma proposes underwritten offering of common stock
- Seeking Alpha’s Quant Rating on BridgeBio Pharma
- Historical earnings data for BridgeBio Pharma